Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Stage IV Gastric Cancer With Metastasis 1Solid Tumor 1Recurrence 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

lenvatinib 3Surgical Procedures, Operative 3Hepatectomy 3Cholangiopancreatography, Endoscopic Retrograde 3Blood Specimen Collection 3Oxaliplatin 2Liquid Biopsy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Drug Therapy 2Base Sequence 2pembrolizumab 1gemcitabine-oxaliplatin regimen 1envafolimab 1Vascular Endothelial Growth Factor A 1Urination 1Tegafur 1Shadowing Technique, Histology 1S 1 (combination) 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Photochemotherapy 1Patient Reported Outcome Measures 1Pancreaticoduodenectomy 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microbiota 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cholangiocarcinoma × S 1 (combination) × Clear all
NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Fudan University

Unknown
160 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡